Pancreatic Cancer Clinical Trials

Find Pancreatic Cancer Clinical Trials Near You

Artificial Intelligence in Endoscopic Ultrasound

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The objective of the study is to determine if this artificial intelligence system is capable of detecting abnormalities in the pancreas that are identified by an endoscopist at endoscopic ultrasound procedures.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: f
View:

• Age ≥ 18 years

• Any patient undergoing endoscopic ultrasound examination

Locations
United States
Florida
Orlando Health
RECRUITING
Orlando
Contact Information
Primary
Shyam Varadarajulu, MD
shyam.varadarajulu@orlandohealth.com
321-841-2431
Backup
Barbara Broome
barbara.broome@orlandohealth.com
321-841-4356
Time Frame
Start Date: 2024-01-19
Estimated Completion Date: 2027-12
Participants
Target number of participants: 310
Treatments
Patients undergoing endoscopic ultrasound procedures
Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.
Related Therapeutic Areas
Sponsors
Leads: Orlando Health, Inc.

This content was sourced from clinicaltrials.gov